Sarim Khan

Sarim Khan is co-founder and CEO of Triomics, a New York-based startup building oncology-specific AI agents that read the thousands of pages inside a cancer patient's chart so that clinicians don't have to. A chemical engineer trained at IIT Roorkee with a brief stint researching polymer gels in brain tissue at MIT, he started Triomics in 2021 with college friend Hrituraj Singh, went through Y Combinator's W21 batch, and by mid-2026 had raised $22 million in Series B financing led by Battery Ventures and deployed the platform at Memorial Sloan Kettering, Yale Cancer Center, and four of the top ten U.S. News cancer hospitals.